ABBV
AbbvieยทNYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ABBV Profile
Abbvie Inc.
A global, diversified research-based biopharmaceutical company positioned for success with a comprehensive product portfolio that has leadership positions across immunology, hematologic oncology, neuroscience, aesthetics and eye care
1 North Waukegan Road, North Chicago, Illinois 60064-6400
Global, diversified research-based biopharmaceuticals
Abbvie Inc. was incorporated in Delaware on April 10, 2012 and holds Abbott's former research-based pharmaceutical business. The company is a global, research-based biopharmaceutical company. Abbvie develops and markets advanced therapies that address some of the world's most complex and serious diseases. Abbvie's products focus on the treatment of chronic autoimmune diseases, including rheumatoid arthritis, psoriasis, Crohn's disease; low testosterone; HIV; endometriosis; thyroid disease; Parkinson's disease; and health conditions such as complications associated with chronic kidney disease and cystic fibrosis. Abbvie's promising new drug pipeline includes more than 20 compounds or indications in Phase II or Phase III development, covering important medical specialties such as immunology, virology, oncology, nephrology, neurological diseases and women's health.
